Loading...
Reducing Healthcare Costs in New York with Syringe Exchange Program Implementation
Journal Title
Readers/Advisors
Journal Title
Term and Year
Publication Date
2017-05-04
Book Title
Publication Volume
Publication Issue
Publication Begin
Publication End
Number of pages
Collections
Files
Research Projects
Organizational Units
Journal Issue
Abstract
This paper explores the cost-effectiveness of New York State-approved syringe exchange programs (SEPs), and provides an estimate of the annual savings in healthcare costs due to these programs. The research utilizes the simplified circulation model that estimated cost savings in Laufer’s (2001) study, however with the most recent data. The cost-effectiveness analysis used data provided by seventeen SEPs, as well as published data for the most recent 12-month period available, and treatment costs from the literature. An estimated 1,608 human immunodeficiency virus (HIV) cases are averted annually in the injection drug user (IDU) population, which translates to about $51,754,152 in treatment cost savings each year due to syringe exchange programs in New York. This research further demonstrates the cost-effectiveness of syringe exchange as prevention strategy.